Literature DB >> 27549789

The role of Epac in the heart.

Takayuki Fujita1, Masanari Umemura2, Utako Yokoyama2, Satoshi Okumura2,3, Yoshihiro Ishikawa4.   

Abstract

As one of the most important second messengers, 3',5'-cyclic adenosine monophosphate (cAMP) mediates various extracellular signals including hormones and neurotransmitters, and induces appropriate responses in diverse types of cells. Since cAMP was formerly believed to transmit signals through only two direct target molecules, protein kinase A and the cyclic nucleotide-gated channel, the sensational discovery in 1998 of another novel direct effecter of cAMP [exchange proteins directly activated by cAMP (Epac)] attracted a great deal of scientific interest in cAMP signaling. Numerous studies on Epac have since disclosed its important functions in various tissues in the body. Recently, observations of genetically manipulated mice in various pathogenic models have begun to reveal the in vivo significance of previous in vitro or cellular-level findings. Here, we focused on the function of Epac in the heart. Accumulating evidence has revealed that both Epac1 and Epac2 play important roles in the structure and function of the heart under physiological and pathological conditions. Accordingly, developing the ability to regulate cAMP-mediated signaling through Epac may lead to remarkable new therapies for the treatment of cardiac diseases.

Entities:  

Keywords:  Catecholamine; Epac; Heart; Heart disease; cAMP

Mesh:

Substances:

Year:  2016        PMID: 27549789     DOI: 10.1007/s00018-016-2336-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  131 in total

1.  Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs.

Authors:  J de Rooij; H Rehmann; M van Triest; R H Cool; A Wittinghofer; J L Bos
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

2.  EPAC regulation of cardiac EC coupling.

Authors:  Alan V Smrcka; Emily A Oestreich; Burns C Blaxall; Robert T Dirksen
Journal:  J Physiol       Date:  2007-09-20       Impact factor: 5.182

3.  Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.

Authors:  Lianghui Zhang; Sundeep Malik; Jinjiang Pang; Huan Wang; Keigan M Park; David I Yule; Burns C Blaxall; Alan V Smrcka
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.

Authors:  Haijun Chen; Tamara Tsalkova; Fang C Mei; Yaohua Hu; Xiaodong Cheng; Jia Zhou
Journal:  Bioorg Med Chem Lett       Date:  2012-04-26       Impact factor: 2.823

5.  Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Authors:  Emily A Oestreich; Sundeep Malik; Sanjeewa A Goonasekera; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

Review 6.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 7.  Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.

Authors:  Frank Lezoualc'h; Loubina Fazal; Marion Laudette; Caroline Conte
Journal:  Circ Res       Date:  2016-03-04       Impact factor: 17.367

8.  Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy.

Authors:  Coskun Ulucan; Xu Wang; Erdene Baljinnyam; Yunzhe Bai; Satoshi Okumura; Motohiko Sato; Susumu Minamisawa; Shinichi Hirotani; Yoshihiro Ishikawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-08       Impact factor: 4.733

9.  Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice.

Authors:  Kenji Suita; Takayuki Fujita; Nozomi Hasegawa; Wenqian Cai; Huiling Jin; Yuko Hidaka; Rajesh Prajapati; Masanari Umemura; Utako Yokoyama; Motohiko Sato; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

10.  MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.

Authors:  Alessandra Castaldi; Tania Zaglia; Vittoria Di Mauro; Pierluigi Carullo; Giacomo Viggiani; Giulia Borile; Barbara Di Stefano; Gabriele Giacomo Schiattarella; Maria Giovanna Gualazzi; Leonardo Elia; Giuliano Giuseppe Stirparo; Maria Luisa Colorito; Gianluigi Pironti; Paolo Kunderfranco; Giovanni Esposito; Marie-Louise Bang; Marco Mongillo; Gianluigi Condorelli; Daniele Catalucci
Journal:  Circ Res       Date:  2014-05-07       Impact factor: 17.367

View more
  25 in total

Review 1.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

2.  Estrogen deficiency compromised the β2AR-Gs/Gi coupling: implications for arrhythmia and cardiac injury.

Authors:  Hongjian Hou; Zhiwei Zhao; Jeremiah Ong'achwa Machuki; Lin Zhang; Yan Zhang; Lu Fu; Jinxia Wu; Yuyu Liu; Sian E Harding; Hong Sun
Journal:  Pflugers Arch       Date:  2018-01-02       Impact factor: 3.657

3.  Early effects of Epac depend on the fine-tuning of the sarcoplasmic reticulum Ca2+ handling in cardiomyocytes.

Authors:  N Lezcano; J I E Mariángelo; L Vittone; X H T Wehrens; M Said; C Mundiña-Weilenmann
Journal:  J Mol Cell Cardiol       Date:  2017-10-14       Impact factor: 5.000

4.  Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia.

Authors:  Diana J Goode; Derek C Molliver
Journal:  J Neurosci       Date:  2021-02-16       Impact factor: 6.167

Review 5.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

6.  Noradrenaline up-regulates volume-regulated chloride current by PKA-independent cAMP/exchange protein activated by cAMP pathway in human atrial myocytes.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Yan Wang; Hai-Ying Sun; Clive M Baumgarten; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

7.  Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.

Authors:  Sirirat Surinkaew; Mona Aflaki; Abhijit Takawale; Yu Chen; Xiao-Yan Qi; Marc-Antoine Gillis; Yan-Fen Shi; Jean-Claude Tardif; Nipon Chattipakorn; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

8.  The functional association between the sodium/bicarbonate cotransporter (NBC) and the soluble adenylyl cyclase (sAC) modulates cardiac contractility.

Authors:  María S Espejo; Alejandro Orlowski; Alejandro M Ibañez; Romina A Di Mattía; Fernanda Carrizo Velásquez; Noelia S Rossetti; María C Ciancio; Verónica C De Giusti; Ernesto A Aiello
Journal:  Pflugers Arch       Date:  2019-11-22       Impact factor: 3.657

Review 9.  Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment.

Authors:  Naveen Kumar; Peeyush Prasad; Eshna Jash; Megha Saini; Amjad Husain; Aaron Goldman; Seema Sehrawat
Journal:  Mol Cell Biochem       Date:  2018-02-07       Impact factor: 3.396

10.  Nitric oxide down-regulates voltage-gated Na+ channel in cardiomyocytes possibly through S-nitrosylation-mediated signaling.

Authors:  Pu Wang; Mengyan Wei; Xiufang Zhu; Yangong Liu; Kenshi Yoshimura; Mingqi Zheng; Gang Liu; Shinichiro Kume; Masaki Morishima; Tatsuki Kurokawa; Katsushige Ono
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.